Sp818
MAKING TELEMEDICINE MORE EFFECTIVE AND PATIENT-CENTERED
Date
May 8, 2023
Explore related products in the following collection:
Society: AGA
The landscape of digital technologies in gastroenterology is growing dramatically. However, it is difficult to identify which approaches have been effective and which ones have not achieved their promise yet. The goal of this sessions is to take a real-world approach to exploring how some examples of digital health are being used today in the field of gastroenterology, and how they can be implemented appropriately so they benefit patients and practices. This is means to be a practical guide for all types of GI clinics. LIVE STREAM SESSION
The landscape of digital technologies in gastroenterology is growing dramatically. However, it is difficult to identify which approaches have been effective and which ones have not achieved their promise yet. The goal of this sessions is to take a real-world approach to exploring how some examples of digital health are being used today in the field of gastroenterology, and how they can be implemented appropriately so they benefit patients and practices. This is means to be a practical guide for all types of GI clinics. LIVE STREAM SESSION
Presenter
NYU Langone Health
Tracks
Related Products
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
PANEL DISCUSSION
The landscape of digital technologies in gastroenterology is growing dramatically. However, it is difficult to identify which approaches have been effective and which ones have not achieved their promise yet…
